Molecular mechanisms and future implications of VEGF/VEGFR in cancer therapy

SA Patel, MB Nilsson, X Le, T Cascone, RK Jain… - Clinical Cancer …, 2023 - AACR
Angiogenesis, the sprouting of new blood vessels from existing vessels, is one of six known
mechanisms employed by solid tumors to recruit blood vessels necessary for their initiation …

Bone metastasis: mechanisms, therapies, and biomarkers

P Clézardin, R Coleman, M Puppo… - Physiological …, 2021 - journals.physiology.org
Skeletal metastases are frequent complications of many cancers, causing bone
complications (fractures, bone pain, disability) that negatively affect the patient's quality of …

Management of metastatic clear cell renal cell carcinoma: ASCO guideline

WK Rathmell, RB Rumble… - Journal of Clinical …, 2022 - ascopubs.org
PURPOSE To provide recommendations for the management of patients with metastatic
clear cell renal cell carcinoma (ccRCC). METHODS An Expert Panel conducted a systematic …

Resistance mechanisms to anti-angiogenic therapies in cancer

Y Haibe, M Kreidieh, H El Hajj, I Khalifeh… - Frontiers in …, 2020 - frontiersin.org
Tumor growth and metastasis rely on tumor vascular network for the adequate supply of
oxygen and nutrients. Tumor angiogenesis relies on a highly complex program of growth …

[HTML][HTML] Current and emerging therapies for first-line treatment of metastatic clear cell renal cell carcinoma

MB Atkins, NM Tannir - Cancer treatment reviews, 2018 - Elsevier
There has been significant progress in the treatment of patients with advanced clear cell
renal cell carcinoma (ccRCC), with improved knowledge of disease biology and the …

[HTML][HTML] Metastatic bone disease: Pathogenesis and therapeutic options: Up-date on bone metastasis management

S D'Oronzo, R Coleman, J Brown, F Silvestris - Journal of bone oncology, 2019 - Elsevier
Bone metastases (BM) are a common complication of cancer, whose management often
requires a multidisciplinary approach. Despite the recent therapeutic advances, patients with …

Systemic treatment of metastatic clear cell renal cell carcinoma in 2018: current paradigms, use of immunotherapy, and future directions

AKA Lalani, BA McGregor, L Albiges, TK Choueiri… - European urology, 2019 - Elsevier
Context Systemic therapy for metastatic clear cell renal cell carcinoma (mccRCC) has
greatly evolved over the last 15 yr. More recently, combination strategies involving …

Towards individualized therapy for metastatic renal cell carcinoma

RR Kotecha, RJ Motzer, MH Voss - Nature reviews Clinical oncology, 2019 - nature.com
Over the past decade, the treatment landscape for patients with metastatic renal cell
carcinoma (RCC) has evolved dramatically. The therapeutic options available have …

Bone metastases

RE Coleman, J Brown, I Holen - Abeloff's clinical oncology, 2020 - Elsevier
Bone metastasis is a major cause of morbidity in persons with cancer. Complications include
pain, impaired mobility, pathological fracture, spinal cord compression, cranial nerve …

Evolving cancer–niche interactions and therapeutic targets during bone metastasis

RL Satcher, XHF Zhang - Nature Reviews Cancer, 2022 - nature.com
Many cancer types metastasize to bone. This propensity may be a product of genetic traits of
the primary tumour in some cancers. Upon arrival, cancer cells establish interactions with …